Cyclodextrins in acetazolamide eye drop formulations

Pharmazie

Volumn 53, Issue 8, 1998, Pages 559-562

  Ammar, H O ^a   El Nahhas, S A ^a   Khalil, R M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 O DIMETHYL BETA CYCLODEXTRIN; ACETAZOLAMIDE; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CARBONATE DEHYDRATASE INHIBITOR; CYCLODEXTRIN; EYE DROPS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NONHUMAN; RABBIT; TOPICAL DRUG ADMINISTRATION;

ACETAZOLAMIDE; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CYCLODEXTRINS; EXCIPIENTS; HALF-LIFE; MALE; OPHTHALMIC SOLUTIONS; RABBITS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0031845103     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Grove, J.; Gautheron, P.; Plazonnet, B.; Sugrue, M. F.: J. Ocul. Pharmacol. 4, 279 (1988)
2. Lewis, R. A.; Schoenwald, R. D.; Burfknecht, C. F.: J. Ocul. Pharmacol. 4, 215 (1988)
3. Sugrue, M. F.; Mallorga, P.; Schwam, H.; Baldwin, J. J.; Ponti Cello, G. S.: Curr. Eye Res. 9, 607 (1990b)
4. Antonaroli, S.; Bianco, A.; Brufani, M.; Callai, L.; Baido, G. L.; Potier, E.; Bonomi, L.; Pefetti, S.; Fiaschi, A. I.; Segre, G.: J. Med. Chem. 35, 2697 (1992)
5. Szejtli, J.; in: Davies, J. E. D. (Ed.): Topics in Inclusion Science, Kluwer Academic Publications, Dordrecht 1988
6. Uekama, K.; Otagiri, M.: CRC Crit. Rev. Ther. Drug Carrier Syst. 3, 1 (1987)
7. Szejtli, J.; Smolen,; in: Ball, I. A. (ed.): Controlled Drug Bioavailability, p. 265, John Wiley and Sons, New York 1985
8. Uekama, K.; Otagiri, M.: CRC Crit. Rev. Ther. Drug Carrier Syst. 3, 1 (1987)
9. Saenger, W.; Atwood, J. L.; in: Davies, J. E. D.; MacNicol, D. D. (eds.): Inclusion Compounds, Vol. 2; p. 231, Academic Press, London 1984
10. Uekama, K.; Irie, T.; in: Duchene, D. (Ed.): Cyclodextrins and their Industrial Uses, p. 211, Editions de Sante, Paris 1987
11. Loftsson, T.; Frioriksdottir, H.; Thorisdottir, S.; Stefansson, E.; Siguroardottir, A. M.; Guomundsson, T.: Eur. J. Pharm. Sci. 1, 175 (1994)
12. Loftsson, T.; Frioriksdottir, H.; Thorisdottir, S.; Stefansson, E.; Siguroardottir, A. M.; Guomundsson, T.: J. Pharm. Pharmacol. 46, 503 (1994)
13. Martin, A.; Swarbrick, J.; Cammarata, A.: Physical Chemical Principals in the Pharmaceutical Sciences, 3rd Edn., p. 314, Lea and Febiger, Philadelphia 1983
14. Meier, J.; Nuesch, E.; Schmitt, R.: Europ. J. Clinical Pharmacol. 7, 429 (1974)
15. Masuda, K.; Ikari, T.; Terashima, A.; Matsuyama, T.: Yakugaku Zasshi 102, 874 (1982)
16. Reddy, I. K.; Bodor, N. S.: J. Pharm. Sci. 83, 450 (1994)
17. Rajewski, R. A.; Stella, V. J.: J. Pharm. Sci. 85, 1142 (1996)
18. Martlin, E.; Verhoef, J. C.; Romeijn, S. G.; Merkus, F. W. H.: Pharm. Res. 12, 1151 (1995)
19. Matsubara, K., Kazuya, A.; Irie, T.; Uekama, K.: J. Pharm. Sci. 84, 1295 (1995)
20. Highuchi, T.; Lach, J. L.: J. Am. Pharm. Assoc. Sci. Edn. 43, 349 (1954)
21. Tsuruoka, M.; Hashimoto, T.; Seo, H.; Ichimasa, S.; Ueno, O.; Fujinaga, T.; Otagiri, M.; Uekame, K.: Yakugaku Zasshi, 101, 360 (1981)
22. Wanger, J. G.: Fundamentals of Clinical Pharmacokinetics, 1st Edn., p. 71, Drug Intelligence Publications, Inc., Hamilton, Illinois, 1975